Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

639.65 (INR) • At close December 27, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Omzet 2,087.022,367.1412,260.9671,878.7561,585.6781,668.2561,265.3291,438.7041,434.8791,381.5091,438.5091,664.6451,765.1391,609.551,395.9341,361.9761,500.94
Kosten van de omzet 1,434.43931.039961.057809.34562.311729.321612.945589.497591.233686.829647.06861.622845.459830.002755.023789.032913.058
Brutowinst 652.591,436.1021,299.911,069.4161,023.367938.935652.384849.207843.646694.68791.449803.023919.68779.548640.911572.945587.882
Brutowinstmarge 0.3130.6070.5750.5690.6450.5630.5160.590.5880.5030.550.4820.5210.4840.4590.4210.392
Onderzoek- en ontwikkelingskosten 0003.4581.5411.2093.7435.6444.6883.2855.5486.93300000
Algemene en administratieve kosten 38.0557.64101.72840.6948.96814.9656.93093.71900.4520.400000
Verkoop- en marketingkosten 163.36186.08153.175129.901178.446131.977112.4570109.955038.54738.26200000
Verkoop-, algemene en administratieve kosten 438.55243.72254.903170.595187.414146.942119.387345.635203.674334.233604.959615.01200000
Overige kosten 057.3391.7773.565758.1881.321646.058808.0360.001633.3780.0152.9113.214653.649500.948428.166472.45
Bedrijfskosten 438.551,106.6391,052.36881.552945.602854.421765.445808.036750.561633.378712.924729.556778.891653.649500.948428.166472.45
Bedrijfsresultaat 214.04338.85239.87187.86474.02783.193-111.265143.96740.75216.71725.29822.45197.68592.681105.00198.98551.919
Bedrijfsresultaat ratio 0.1030.1430.1060.10.0470.05-0.0880.10.0280.0120.0180.0130.0550.0580.0750.0730.035
Totaal overige inkomsten en kosten netto 84.659.2320.9730.85920.1215.514-3.206104.281-52.333-44.454-53.331-48.181-40.04-30.616-31.332-39.45-57.284
Inkomen voor belasting 298.69348.085273.191218.72394.14890.028-116.267143.96740.75316.71725.31325.363100.89992.681105.00198.98551.919
Inkomen voor belasting ratio 0.1430.1470.1210.1160.0590.054-0.0920.10.0280.0120.0180.0150.0570.0580.0750.0730.035
Belastingkosten 74.0680.87277.32148.1415.4417.867-0.76125.328.2115.0064.1067.03626.3320.88512.58137.26221.158
Nettowinst 224.63267.21188.55170.58378.70872.161-115.506118.64732.54211.71121.20718.32774.56871.79692.4261.72330.76
Nettowinstmarge 0.1080.1130.0830.0910.050.043-0.0910.0820.0230.0080.0150.0110.0420.0450.0660.0450.02
WPA (Winst Per Aandeel) 8.4910.27.26.5132.75-4.414.531.240.450.810.72.852.743.762.351.17
Verwaterde WPA 8.4610.27.26.5132.75-4.414.531.240.450.810.72.852.743.762.351.17
EBITDA 323.46363.96284.53234.718110.587107.641-103.406190.355124.65988.372107.386103.774169.839147.908160.813153.64128.624
EBITDA ratio 0.1550.1680.1240.1230.0690.063-0.080.0420.0860.0640.0740.060.0940.0920.1150.1150.088